Global Longlife Hospital and Research Ltd (GLHRL) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Global Longlife Hospital and Research Ltd on NSE and BSE, with an AI summary of each filing.
Approval of Unaudited Financial Results For the Half year ended September 30th 2026
Financial Result · 04 Nov 2026, 10:44 pm
Asahi Enterprise Reports H1 FY27 Financial Results with Net Profit Turnaround Asahi Enterprise reported zero revenue from operations for the half year ended 30th Sep'26, matching H1 FY26 and H2 FY26. Other income rose sharply to Rs 56.75 lakhs from Rs 0.52 lakhs in H1 FY26. Total expenses stood at Rs 53.56 lakhs compared to Rs 59.71 lakhs YoY. Net profit turned positive to Rs 2.36 lakhs versus a net loss of Rs 132.34 lakhs in H1 FY26. Basic EPS stood at Rs 0.02. Shareholders approved shifting main business objects to trading agricultural commodities.
Outcome of Meeting of Board of Directors held today i.e. Wednesday, November 4, 2026 for Consideration and approval of Unaudited Financial Results for the Half Year ended on September 30, 2026.
Outcome · 04 Nov 2026, 10:19 pm
Asahi Enterprise Reports H1 FY27 Results, Pivots to Agri-Commodities Trading Asahi Enterprise reported total income of ₹56.75 lakh for the half year ended 30th Sep'26, driven entirely by other income, compared to ₹0.52 lakh in H1 FY26 and nil in H2 FY26. Revenue from operations remained nil. Total expenses stood at ₹53.56 lakh, resulting in a net profit of ₹2.36 lakh versus a net loss of ₹132.34 lakh in H1 FY26. Diluted EPS stood at ₹0.02. Shareholders approved shifting the core business object from healthcare services to trading in agricultural produce and commodities.
Voting Results in respect of First Extra Ordinary General Meeting held on October 30, 2026
Annual General Meeting · 01 Nov 2026, 1:27 am
Asahi Enterprise Shareholders Approve Name Change CA Certificate Ratification at EGM Asahi Enterprise Limited announced the voting results for its First EGM held on 30th Oct'26. Shareholders unanimously passed a special resolution ratifying the submission of a Practicing Chartered Accountant's Certificate under Regulation 45 of SEBI LODR Regulations regarding the company's name change from Global Longlife Hospital and Research Limited. Out of 10.50m total shares, 561,990 votes were polled across 26 members (representing 5.35% of outstanding shares), with 100% of votes cast in favor and zero dissenting or invalid votes.
Proceedings of the First Extra Ordinary General Meeting of FY 2026-2027.
Extra Ordinary General Meeting · 30 Oct 2026, 11:14 pm
Asahi Enterprise Concludes EGM on Name Change Certification Ratification Asahi Enterprise Limited (formerly Global Longlife Hospital and Research Limited) conducted its first Extra Ordinary General Meeting for FY 2026-27 on 30th Oct'26 via video conferencing. The sole agenda transacted via special resolution was the ratification of a Practicing Chartered Accountant's Certificate under Regulation 45 of SEBI LODR Regulations regarding the company's name change. Voting was executed through remote e-voting and e-voting during the meeting, with final results to be disclosed post the Scrutinizer’s report.
Global Longlife Hospital And Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve Unaudited ....
Intimation · 04 Nov 2026, 5:30 am
Asahi Enterprise Board to Consider H1 Results on 4th Nov'26 Asahi Enterprise Limited (formerly Global Longlife Hospital and Research Limited) has scheduled a Board of Directors meeting for 4th Nov'26. The board will inter alia consider and approve the unaudited financial results alongside the limited review report for the half-year ended 30th Sep'26. In compliance with insider trading regulations, the trading window for company securities remains closed for designated persons and will reopen 48 hours post the declaration of the financial results.
Notice of EGM
Extra Ordinary General Meeting · 07 Oct 2026, 9:59 pm
Asahi Enterprise Convenes EGM to Ratify Name-Change Regulatory Filings Asahi Enterprise Limited (formerly Global Longlife Hospital and Research Limited) scheduled an Extraordinary General Meeting on 30th Oct'26 to seek shareholder ratification for submitting a Practicing Chartered Accountant's Certificate under SEBI LODR Regulation 45. The certificate confirms compliance with name-change requirements, verifying that ₹1,702.15 Lakhs (71.73% of total assets of ₹2,372.98 Lakhs as of 30th Jun'26) is allocated to new activities. The remote e-voting window runs from 27th Oct'26 to 29th Oct'26, with the cut-off record date set for 23rd Oct'26.
Outcome of the Meeting of Board of Directors
Others (Uncategorized) · 03 Oct 2026, 9:08 pm
Asahi Enterprise Board Approves Convening EGM on 30th Oct'26 The Board of Directors of Asahi Enterprise Limited, at its meeting on 3rd Oct'26, approved convening the company's First Extra-Ordinary General Meeting (EGM) of FY27 on 30th Oct'26 at 12:15 PM IST via video conferencing to seek shareholder approval for proposed issuances. The Board adopted the EGM notice, appointed M/s Insiya Nalawala & Associates as scrutinizer for remote e-voting, and engaged NSDL as the remote e-voting agency alongside approving the e-voting schedule.
Change in name of the company.
Others (Uncategorized) · 28 Sept 2026, 11:46 pm
Global Longlife Hospital and Research Renamed to Asahi Enterprise Global Longlife Hospital and Research Limited announced that it has received approval from the Registrar of Companies (ROC), Central Processing Centre, Ministry of Corporate Affairs, to change its corporate name to Asahi Enterprise Limited. The ROC issued the Certificate of Incorporation reflecting the name change on 25th Sep'26, which serves as the effective date. Following the alteration, the company’s Corporate Identification Number (CIN) is L46300GJ2012PLC068700.
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Abhishek Ashvinbhai Kamdar HUF
Acquisition/ Disposal of Shares · 26 Sept 2026, 5:51 pm
Abhishek Ashvinbhai Kamdar HUF Acquires 5.09% Stake in Global Longlife Hospital Abhishek Ashvinbhai Kamdar HUF acquired 5,35,000 equity shares, representing a 5.09% equity and voting stake, in Global Longlife Hospital and Research Ltd via open market transactions on 25th Sep'26. Prior to this transaction, the acquirer, categorized as non-promoter, held no equity in the company. Following the acquisition, the total shareholding stands at 5.09% of the target company's total paid-up and diluted equity capital comprising 1,05,00,000 equity shares aggregating to Rs. 10.50 crore.
Alteration in the Object Clause of Memorandum of Association of the Company.
Others (Uncategorized) · 25 Aug 2026, 11:30 pm
Global Longlife Hospital Expands Business Scope Beyond Healthcare Global Longlife Hospital and Research Ltd. (BSE: 543520) has received MCA approval to alter its Objects Clause, effective 25 Aug'26. The company is diversifying its operations significantly beyond its core hospital business. The revised scope includes manufacturing, trading, and dealing in agricultural commodities, food products, spices, and textiles. The firm will also engage in bullion markets, trading precious metals like gold and silver. This strategic pivot broadens the company's operational framework into unrelated, diversified business segments.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Trade Pulse Broking Pvt Ltd
Acquisition/ Disposal of Shares · 19 Aug 2026, 4:28 pm
Trade Pulse Broking Acquires Stake in Global Longlife Hospital Trade Pulse Broking Pvt Ltd, a non-promoter entity, acquired 268,000 shares (2.55% stake) in Global Longlife Hospital and Research Ltd via an open market transaction on 07-Aug-26. This purchase increased Trade Pulse Broking's total holding from 500,000 shares (4.76%) to 768,000 shares (7.31%). The transaction raises their stake above the 5% substantial acquisition threshold, triggering the regulatory disclosure. The total voting capital after the acquisition is 768,000 shares, representing 7.31% of the total diluted capital.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhruv Jani
Acquisition/ Disposal of Shares · 13 Aug 2026, 3:51 pm
Global Longlife Hospital: Promoter Dhruv Jani Reduces Stake Promoter Dhruv Jani of Global Longlife Hospital (BSE: 543520) has sold 722,000 equity shares via the open market between Aug 10, '26, and Aug 12, '26. This transaction reduced his holding from 722,990 shares (6.89% stake) to just 990 shares (0.01% stake). The sale represents a significant divestment, reducing his ownership by 6.88%. The company's total equity share capital remains unchanged at 10.5M shares of Rs. 10 each. This action constitutes a substantial reduction in promoter group ownership.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhruv Sureshkumar Jani
Acquisition/ Disposal of Shares · 10 Aug 2026, 5:04 pm
Promoter Group Sells 9.52% Stake in Global Longlife Hospital Promoter group member Dhruv Sureshkumar Jani sold 10,00,000 equity shares of Global Longlife Hospital and Research Limited (BSE: 543520) via open market transactions between 06-Aug-26 and 07-Aug-26. This sale represents a 9.52% stake in the company's total share capital. Following the transaction, Mr. Jani's shareholding in the company decreased from 16.41% (17,22,990 shares) to 6.89% (7,22,990 shares). The company's total equity share capital remains unchanged at Rs. 10.50 crore.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhruv Jani
Acquisition/ Disposal of Shares · 03 Aug 2026, 6:02 pm
Promoter Group Member Sells Stake in Global Longlife Hospital Promoter group member Dhruv Sureshkumar Jani sold 6,78,000 equity shares of Global Longlife Hospital and Research Ltd. via the open market between Jul 01, '26 and Jul 30, '26. The transaction represented 6.46% of the company's total share capital. Following the sale, Jani's stake decreased from 24,00,990 shares (22.87%) to 17,22,990 shares (16.41%). The company's total equity share capital remained unchanged at Rs. 10.50 crore post-transaction, as disclosed on Aug 01, '26.
Appointment/Regularization of Mr. Hiren Mandaliya (DIN: 11636452) as Non-Executive Independent Director.
Change in Management · 26 Jun 2026, 10:03 pm
Re-appointment of Mr. Manasvi Manu Thapar (DIN: 07486932), as Independent Director of the Company.
Change in Management · 26 Jun 2026, 9:59 pm
Re-appointment of Mr. Dhruv Jani as Managing Director of the Company.
Change in Management · 26 Jun 2026, 9:54 pm
Consolidated Scrutinizer''s Report
Annual General Meeting · 26 Jun 2026, 9:35 pm
Proceedings of 15th Annual General Meeting of the company held on June 25, 2026.
Annual General Meeting · 25 Jun 2026, 8:29 pm
Annual Report for the Financial Year 2025-2026.
Others (Uncategorized) · 02 Jun 2026, 10:11 pm
Global Longlife Hospital Reports FY26 Loss, Proposes Name and Business Change For FY26, Global Longlife Hospital and Research Ltd reported a net loss of ₹171.95 Lakhs, a sharp reversal from a ₹19.87 Lakhs profit in FY25, as revenue from operations fell to nil from ₹57.73 Lakhs. Earning Per Share was ₹(1.64) versus ₹0.19 YoY. The company's 15th AGM on 25th Jun'26 will seek shareholder approval to change its name and alter its object clause to enter businesses like agriculture commodities and textiles, signaling a strategic pivot from its current healthcare operations.
Notice of 15th Annual General Meeting.
Annual General Meeting · 02 Jun 2026, 10:06 pm
Global Longlife Hospital to Seek Shareholder Approval for Strategic Overhaul Global Longlife Hospital will hold its 15th AGM on Jun 25, '26, to seek shareholder approval for significant strategic changes. Key resolutions include changing the company name to Kanzi/Asahi/Siddhaa Enterprise Limited and altering the object clause to diversify into agri-commodities, textiles, and bullion trading. The agenda also includes the re-appointment of Managing Director Dhruv Jani for five years with a proposed salary up to ₹36 lakh per annum and the appointment/re-appointment of several directors. These proposals signal a major pivot from its current healthcare business.
Re-appointment of Mr. Manasvi Manu Thapar as Independent Director of the company for second term of five consecutive financial year subject to the approval of shareholders in the ensuing 15th AGM.
Change in Management · 30 May 2026, 8:30 pm
Global Longlife Hospital: Independent Director Re-appointed for Second Term Global Longlife Hospital's board approved the re-appointment of Manasvi Manu Thapar as an Independent Director on 30 May'26. The re-appointment is for a second five-year term, effective from 10 Sep'26 to 09 Sep'31. This decision is subject to shareholder approval. Mr. Thapar is not related to any other director and is not debarred from holding office by any SEBI order. The re-appointment ensures continuity in board oversight and governance.
Re-appointment of Mr. Dhruv Jani as Managing Director for term of five year subject to the approval of shareholders in the ensuing 15th AGM.
Change in Management · 30 May 2026, 8:28 pm
Global Longlife Hospital Re-appoints Dhruv Jani as Managing Director for Five Years Global Longlife Hospital's board approved the re-appointment of Mr. Dhruv Jani (DIN: 03154680) as Managing Director on 30 May'26. The new five-year term is effective from 10 Sep'26 to 09 Sep'31, subject to shareholder approval. Mr. Jani, the company's Promoter, has served as MD since 10 Sep'21 and is responsible for finance, overall management, and operations. This move signals leadership continuity for the company. There are no debarments against him from SEBI.
Appointment of Secretarial Auditor for FY 2026-2027.
Change in Management · 30 May 2026, 8:26 pm
Global Longlife Hospital Appoints Secretarial Auditor for FY27 Global Longlife Hospital & Research Ltd. (BSE: 543520) announced the appointment of M/s Insiya Nalawala and Associates as its Secretarial Auditor for the fiscal year 2026-2027. The appointment was finalized during a Board of Directors meeting held on 30 May'26. This is a routine corporate governance disclosure, ensuring compliance with SEBI LODR regulations. The firm has experience in Company Law, Securities Law, and Labour Law. No relationships were disclosed between the appointee and the company's directors.
Appointment of Internal Auditor for FY 2026-2027
Change in Management · 30 May 2026, 8:25 pm
Global Longlife Hospital Appoints J J Patel & Associates as Internal Auditor Global Longlife Hospital and Research Ltd. (BSE: 543520) announced the appointment of M/s. J J Patel & Associates, Chartered Accountants (FRN: 133005W) as its internal auditor. The appointment, effective from 30 May'26, is for the fiscal year 2026-2027. The decision was approved by the Board of Directors in a meeting held on the same day. J J Patel & Associates provides services in audit, assurance, GST, income tax, and financial consultancy.